NCT06901505Phase 3Completed

To Evaluate the Efficacy of Three Times Weekly (TIW) Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis

Study sponsor: Akebia Therapeutics

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-08-12Actual
Enrollment · participants353Actual
Source updated2026-11-16Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 3 fields changed

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Aug 2026. After: 12 Aug 2026.

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source

· 4 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 350 participants (planned). After: 353 participants (actual).

Primary completion date changed

Before: Jun 2026. After: Aug 2026.

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview